Search results

ANSTO welcomes the Federal Budget, which supports ongoing operations.

The Australian Industry Becquerel Traceability Program (AIBTP) provides facilities with direct measurement traceability to the Australian standard for the activity of radionuclides used in Positron Emission Tomography (PET).

Production of nuclear medicine generators has resumed, with all relevant quality control checks passed, and medicine to be distributed across Australia from Sunday 25th October 2020.

Scientists from the Walter and Eliza Hall Institute (WEHI) are using the unique immune system of the alpaca and techniques at the Australian Synchrotron as part of research using antibodies to disrupt COVID-19 viral entry into cells.

ANSTO completed an international overnight dash for nuclear medicine earlier this week, chartering three planes to get potentially life-saving children’s cancer treatments from Japan to hospitals across Australia.

Potential new treatments and tools for depression under development.

A team of ANSTO health researchers, staff at the Centre for Accelerator Science and Dr Melanie Ferlazzo, a postdoc from the French National Institute of Health and Medical Research (INSERM), and scientists from the French Space Agency (CNES), are collaborating on investigations to determine the impact of secondary particles on human cells using the new microprobe beamline at ANSTO’s Centre for Accelerator Science.

Radiocarbon dating at ANSTO has supported new archaeological research conducted by Flinders University and the University of Queensland that describes significant earth mound features used for cooking that were created by Aboriginal people in the Riverland region of South Australia.

A research team from ETH Zurich developing and characterizing silicon carbide devices for power electronics, recently spent time at ANSTO’s Centre for Accelerator Science to use a specialised beamline in their investigations.